In the News January 31, 2019

The Deal | Alexion, Caelum Collaborate

Alston & Bird is noted for representing Fortress Biotech, Inc., and Caelum Biosciences Inc. in a deal with Alexion Pharmaceuticals Inc. to develop a treatment for a rare systemic disorder.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.